HR-MS Analysis of the Covalent Binding of Edaravone to 5-Formylpyrimidine Bases and a DNA Oligonucleotide Containing a 5-Formylcytidine Residue. [PDF]
Regnault R +5 more
europepmc +1 more source
Correction: Edaravone Maintains AQP4 Polarity Via OS/MMP9/β-DG Pathway in an Experimental Intracerebral Hemorrhage Mouse Model [PDF]
Zhenhua Wang +9 more
openalex +1 more source
Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment. [PDF]
Genge A +17 more
europepmc +1 more source
Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02). [PDF]
Rothstein J +17 more
europepmc +1 more source
Response to the Letter Regarding "Intratympanic Administration of Edaravone for Sudden Sensorineural Hearing Loss: A Prospective Case Series with Historical Controls. [PDF]
Nitta Y.
europepmc +1 more source
Antioxidative Activity of Remimazolam as a Direct Free Radical Scavenger in Comparison With Midazolam. [PDF]
Matsumoto S +9 more
europepmc +1 more source
Neuronal Damage Induced by Gradual Oxidative Stress in iPSC-Derived Neurons: Implications for Ferroptosis Involvement and ALS Drug Evaluation. [PDF]
Kobayashi H +4 more
europepmc +1 more source
Salivary gland tissue chip screening identifies candidate radioprotective drugs. [PDF]
Piraino LR +6 more
europepmc +1 more source
Edaravone Modulates Neuron Cuproptosis in Ischemic Stroke by Targeting NF-kB Signaling Pathway
Wenhong Zhi +4 more
openalex +2 more sources
Microglial Polarization and Therapeutic Strategies in Post-stroke Neuroinflammation. [PDF]
Chan TYH +4 more
europepmc +1 more source

